미용 임플란트 시장 보고서 : 제품, 원재료, 최종사용자, 지역별(2024-2032년)

The global cosmetic implants market size reached US$ 10.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.3% during 2024-2032.

Cosmetic implants refer to devices or tissues that are placed inside or on the surface of the body. They are generally made from skin, bone, tissues, metal, plastic, ceramic and other materials. They are widely utilized in surgical procedures to improve the overall appearance and rectify deformities caused due to accidents and congenital disorders. At present, cosmetic implants are gaining traction around the world on account of the growing influence of social media and the rising awareness among individuals about physical appearance.

Cosmetic Implants Market Trends:

Rapid economic development, coupled with the improving healthcare infrastructure, represents one of the key factors catalyzing the demand for cosmetic implants across the globe. Besides this, there is a significant rise in the incidences of congenital face disorders and tooth deformities. This, along with the increasing western influence on account of the surging number of individuals who use social media networking platforms, is also contributing to the market growth. Furthermore, the market is driven by the emergence of minimally invasive reconstruction surgeries that assists in improving the appearance and function of abnormal body parts. These procedures are being widely performed by surgeons worldwide for tumor removal, laceration repair, scar revision, hand surgery, and breast reconstruction. Moreover, numerous technological advancements, such as the introduction of hyaluronic acid facial filler and two form-stable silicone gel breast implants, are creating a favorable market outlook. The market is also anticipated to experience growth due to several initiatives undertaken by governing and healthcare agencies of different countries to promote patient awareness about cosmetic implants. For instance, the American Society of Plastic Surgeons (ASPS) and The Plastic Surgery Foundation (The PSF) are sponsoring the Breast Reconstructive Awareness Campaign to educate women about the post-breast cancer diagnosis.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cosmetic implants market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, raw material and end user.

Breakup by Product:

Dental Implants

Breast Implants

Facial Implants

Others

Breakup by Raw Material:

Metals

Polymers

Ceramics

Biomaterials

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Allergan plc (AbbVie Inc.), Danaher Corporation, Dentsply Sirona, Implantech Associates Inc., Institut Straumann AG, Johnson & Johnson, POLYTECH Health & Aesthetics GmbH, Sientra Inc. and Zimmer Biomet Holdings Inc.

Key Questions Answered in This Report

• 1. What was the size of the global cosmetic implants market in 2023?
• 2. What is the expected growth rate of the global cosmetic implants market during 2024-2032?
• 3. What has been the impact of COVID-19 on the global cosmetic implants market?
• 4. What are the key factors driving the global cosmetic implants market?
• 5. What is the breakup of the global cosmetic implants market based on the product?
• 6. What is the breakup of the global cosmetic implants market based on the raw material?
• 7. What are the key regions in the global cosmetic implants market?
• 8. Who are the key players/companies in the global cosmetic implants market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cosmetic Implants Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Dental Implants
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Breast Implants
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Facial Implants
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Raw Material

• 7.1 Metals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Polymers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Ceramics
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Biomaterials
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Specialty Clinics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 3M Company
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Allergan plc (AbbVie Inc.)
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 SWOT Analysis
  • 14.3.3 Danaher Corporation
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Dentsply Sirona
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Implantech Associates Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Institut Straumann AG
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Johnson & Johnson
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 POLYTECH Health & Aesthetics GmbH
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Sientra Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Zimmer Biomet Holdings Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis